Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-BROMO-IMIDAZO[1,5-A]PYRIDINE is a heterocyclic chemical compound with the molecular formula C6H4BrN3. It features both imidazole and pyridine rings, with a bromine atom attached to the 5-position of the imidazole ring. 5-BROMO-IMIDAZO[1,5-A]PYRIDINE is widely recognized for its role in organic synthesis and medicinal chemistry, serving as a fundamental building block for the creation of various biologically active molecules. Its potential biological activities, including antifungal and antibacterial properties, have been a subject of study, and it also finds application as a ligand in coordination chemistry and metal-catalyzed reactions.

885275-77-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 885275-77-4 Structure
  • Basic information

    1. Product Name: 5-BROMO-IMIDAZO[1,5-A]PYRIDINE
    2. Synonyms: 5-BROMO-IMIDAZO[1,5-A]PYRIDINE
    3. CAS NO:885275-77-4
    4. Molecular Formula: C7H5BrN2
    5. Molecular Weight: 197.03
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 885275-77-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.69g/cm3
    6. Refractive Index: 1.688
    7. Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
    8. Solubility: N/A
    9. CAS DataBase Reference: 5-BROMO-IMIDAZO[1,5-A]PYRIDINE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 5-BROMO-IMIDAZO[1,5-A]PYRIDINE(885275-77-4)
    11. EPA Substance Registry System: 5-BROMO-IMIDAZO[1,5-A]PYRIDINE(885275-77-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 885275-77-4(Hazardous Substances Data)

885275-77-4 Usage

Uses

Used in Organic Synthesis:
5-BROMO-IMIDAZO[1,5-A]PYRIDINE is used as a key intermediate in the synthesis of a variety of organic compounds. Its unique structure allows for the creation of new molecules with potential applications in various fields.
Used in Medicinal Chemistry:
In the pharmaceutical industry, 5-BROMO-IMIDAZO[1,5-A]PYRIDINE is utilized as a building block for the development of biologically active compounds. Its incorporation into drug molecules can enhance their therapeutic effects and target specific biological pathways.
Used in Antifungal and Antibacterial Applications:
5-BROMO-IMIDAZO[1,5-A]PYRIDINE demonstrates potential as an antifungal and antibacterial agent. It is used in the development of new antimicrobial drugs to combat resistant strains and improve treatment options for various infections.
Used in Coordination Chemistry:
As a ligand in coordination chemistry, 5-BROMO-IMIDAZO[1,5-A]PYRIDINE is employed to form complexes with metal ions. These complexes have potential applications in catalysis, materials science, and as sensors.
Used in Metal-Catalyzed Reactions:
In the field of catalysis, 5-BROMO-IMIDAZO[1,5-A]PYRIDINE serves as a ligand to modify the properties of metal catalysts, enhancing their efficiency and selectivity in various chemical reactions.

Check Digit Verification of cas no

The CAS Registry Mumber 885275-77-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,7 and 5 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 885275-77:
(8*8)+(7*8)+(6*5)+(5*2)+(4*7)+(3*5)+(2*7)+(1*7)=224
224 % 10 = 4
So 885275-77-4 is a valid CAS Registry Number.
InChI:InChI=1/C7H5BrN2/c8-7-3-1-2-6-4-9-5-10(6)7/h1-5H

885275-77-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-bromoimidazo[1,5-a]pyridine

1.2 Other means of identification

Product number -
Other names Imidazo[1,5-a]pyridine,5-bromo

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:885275-77-4 SDS

885275-77-4Upstream product

885275-77-4Downstream Products

885275-77-4Relevant articles and documents

Synthesis and Characterization of Axially Chiral Imidazoisoquinolin-2-ylidene Silver and Gold Complexes

Grande-Carmona, Francisca,Iglesias-Sigüenza, Javier,álvarez, Eleuterio,Díez, Elena,Fernández, Rosario,Lassaletta, José M.

, p. 5073 - 5080 (2015)

The selective Suzuki cross-coupling of 1,3-dichloroisoquinoline with 2-substituted 1-naphthylboronic acids/esters followed by construction of the imidazo[1,5-b]isoquinoline ring and alkylation constitutes a straightforward route to imidazolium salts fused into an axially chiral biaryl skeleton. Metalation of these azolium salts afforded the corresponding NHC silver complexes, which were used as carbene transfer agents for the synthesis of Au(I) derivatives.

FUSED HETEROCYCLIC DERIVATIVES, THEIR PREPARATION METHODS THEREOF AND MEDICAL USES THEREOF

-

Page/Page column 0246; 0260; 0270-0272; 0320; 0328; 0329, (2019/07/03)

The present invention relates to fused heterocyclic derivatives, processes for their preparation and their use in medicine. Specifically, the present invention relates to a novel derivative represented by the formula (I′), or its pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the derivative or its pharmaceutically acceptable salt thereof, and the method for preparing the derivative and its pharmaceutically acceptable salt thereof. The present invention also relates to the use of the derivative and its pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing the derivative and its pharmaceutically acceptable salt thereof in the preparation of medicines, in particularly as IDO inhibitor medicines, for treating and/or preventing cancers. Wherein each substituent of the formula (I′) is the same as defined in the specification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 885275-77-4